Early Identification of Candida in Intra-abdominal Candidiasis
NCT05264571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2023-07-17
Summary
Intra-abdominal candidiasis remains the first origin of invasive candidiasis in critically ill patients with a mortality up to 60%. This high mortality is partly related to delay of anti-fungal treatment administration. According to experts in the field, new diagnostic methods to rapidly detect Candida in intra-abdominal infections is mandatory because the current strategies suffer from a lack of both sensitivity and specificity.
The calscreener (SYMCEL®) is a new diagnostic tool to rapidly identify the presence of pathogens in biological samples based on micrometabolic activity detection. This technology also allows to measure the metabolic activity of pathogens.
The ICCA project will test the feasibility, the accuracy and the diagnostic performance of the calscreener on an existing biological collection of peritoneal fluid. This collection came from a cohort of critically ill patients with intra-abdominal infection which required abdominal surgery. Intra-abdominal infections consist of bacterial peritonitis and intra-abdominal candidiasis. The presence of pathogens (bacteria and yeast) is already known, the peritoneal fluid being stored after routine analysis (bacteriology / mycology).
In addition to the detection / identification of yeast will be investigated in this project, the cal screener will be used to evaluate the metabolic profile of Candida albicans in the peritoneal fluid, alone and with bacteria. This objective aims to evaluate the virulence of Candida in the peritoneal fluid from a metabolic perspective. The results will be compared to phenotypic and molecular evaluation.
Conditions
- Candida Sepsis
- Candidiasis, Invasive
- Peritonitis Infectious
- Critically Ill
Interventions
- DIAGNOSTIC_TEST
-
calscreener
The calscreener (SYMCEL®) is a new diagnostic tool to rapidly identify the presence of pathogens in biological samples based on micrometabolic activity detection. All living cells produce heat by the chemical and physical processes of life; by monitoring the heat flow over time (J/s, W) a significant amount of information can be obtained regarding the biological system.
- OTHER
-
Metabolic profile
The cal screener allows the measure of metabolic activity of pathogens directly from a sample (here, the peritoneal fluid). The heat production will be compared between peritoneal fluid, with or without addition of bacteria
- OTHER
-
optical microscopy
To explain the metabolic activity, growth and yeast-to-hyphae transition will be analysed using optical microscopy and conventional culture
- OTHER
-
RTqPCR
To explain the metabolic activity, level of expression of 5 Candida albicans virulence genes (UME6, ALS3, SFL2, HWP1 and ECE1) will be address and compared between peritoneal fluid.
Sponsors & Collaborators
-
SYMCEL
collaborator UNKNOWN -
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-17
- Primary Completion
- 2022-06-30
- Completion
- 2023-06-22
Countries
- France
Study Locations
More Related Trials
-
Evaluation of BD Glucan in Peritoneal Fluid for the Diagnosis of Fungal Peritonitis
NCT03469401 ·Status: COMPLETED
-
Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital
NCT00903526 ·Status: UNKNOWN
-
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units
NCT00099775 ·Status: COMPLETED ·Phase: PHASE3
-
Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation
NCT03140748 ·Status: COMPLETED ·Phase: NA
-
Optimal Dosage of Caspofungin in Critically Ill Patients
NCT01994096 ·Status: COMPLETED ·Phase: PHASE4
-
Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
NCT07093203 ·Status: RECRUITING
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
NCT05720728 ·Status: COMPLETED
-
De-escalation - Antifungal Treatment Immunocompromised Patients
NCT03774316 ·Status: COMPLETED
-
Echinocandins Versus Azoles for Candidemia Treatment
NCT03799172 ·Status: COMPLETED
-
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)
NCT00520234 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
NCT02510053 ·Status: UNKNOWN ·Phase: NA
-
Early Discontinuation of Empirical Antifungal Therapy and Biomarkers
NCT03538912 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Drug Monitoring of Antifungals in Intensive Care Units
NCT04502771 ·Status: COMPLETED
-
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
NCT01916057 ·Status: COMPLETED ·Phase: NA
-
A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis
NCT03090334 ·Status: TERMINATED ·Phase: NA
-
The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital
NCT05876962 ·Status: UNKNOWN
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
Risk Factor and Outcome of Candidemia
NCT01249313 ·Status: UNKNOWN
-
Systemic Fungal Infections in ICU Patients
NCT03292224 ·Status: UNKNOWN
-
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
NCT06387667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients
NCT02413892 ·Status: COMPLETED
-
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
NCT00689338 ·Status: COMPLETED ·Phase: PHASE3